Yes, 87% of Oncologists are considering ‘real world’ evidence on product effectiveness and safety, most or all of the time when prescribing treatments. This according to a survey, conducted by Ipsos Healthcare, which asked 257 oncologists from the US, China, Brazil, and Europe about their satisfaction with the direction and pace of their respective local healthcare initiatives and key influencers when making treatment decisions. More here. (Source: eyeforpharma)
You are here: / Are Oncologists Considering Real World Evidence When Recommmending Treatment?